A United Kingdom supplier, with 3 awarded contracts, totalling £54.7m, most recently 7 months ago.
This contract involves a framework agreement with a single supplier for the ongoing supply of a nonavalent human papillomavirus (HPV) vaccine. The vaccines are intended for the vaccination program in Andalusia, Spain. The total value of the contract is €243,676.17. The awarded supplier is Merck Shar
This contract involves the supply of the active ingredient Letermovir Oral 480 mg. The buyer, the Hospital Universitario de Gran Canaria Doctor Negrín, is seeking suppliers to provide this medication, which is essential for patient treatment in the health sector. The total value of the contract is €
This contract involves the supply of Pembrolizumab, a pharmaceutical product, for the health sector. The buyer is OSAKIDETZA - Servicio Vasco de Salud - Organización Central in Spain. The total value of the contract is approximately €54,087,280. The awarded supplier for this contract is Merck, Sharp
